New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

por Dahl, Ola E
Publicado 2012

Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis

por Borgen, Pål O., Dahl, Ola E., Reikeras, Olav
Publicado 2013

The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality, and Prevention

por Dahl, Ola E., Pripp, Are Hugo, Jaradeh, Mark, Fareed, Jawed
Publicado 2023

Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly

por Talsnes, Ove, Hjelmstedt, Fredrik, Dahl, Ola E., Pripp, Are Hugo, Reikerås, Olav
Publicado 2010

The Proportion of Perioperative Mortalites Attributed to Cemented Implantation in Hip Fracture Patients Treated by Hemiarthroplasty

por Pripp, Are Hugo, Talsnes, Ove, Reikerås, Olav, Engesæter, Lars B., Dahl, Ola E.
Publicado 2014

Low-molecular-weight heparin for hip fracture patients treated with osteosynthesis: should thromboprophylaxis start before or after surgery? An observational study of 45,913 hip fr...

por Leer-Salvesen, Sunniva, Dybvik, Eva, Engesaeter, Lars B, Dahl, Ola E, Gjertsen, Jan-Erik
Publicado 2018

Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures: An observational study of 20,241 hem...

por Leer-Salvesen, Sunniva, Dybvik, Eva, Dahl, Ola E, Gjertsen, Jan-Erik, EngesæTer, Lars B
Publicado 2017

Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?

por Leer-Salvesen, Sunniva, Dybvik, Eva, Ranhoff, Anette H., Husebø, Bjørn Liljestrand, Dahl, Ola E., Engesæter, Lars B., Gjertsen, Jan-Erik
Publicado 2020

Correction to: Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?

por Leer-Salvesen, Sunniva, Dybvik, Eva, Ranhoff, Anette H., Husebø, Bjørn Liljestrand, Dahl, Ola E., Engesæter, Lars B., Gjertsen, Jan-Erik
Publicado 2020

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

por Eriksson, Bengt I., Dahl, Ola E., Rosencher, Nadia, Clemens, Andreas, Hantel, Stefan, Feuring, Martin, Kreuzer, Jörg, Huo, Michael, Friedman, Richard J.
Publicado 2015